![Caren Deardorf](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Caren Deardorf
Direktor/Vorstandsmitglied bei
CRINETICS PHARMACEUTICALS, INC.
Vermögen: 609 946 $ am 30.06.2026
Profil
Caren Deardorf is currently Director at Pan Mass Challenge, Independent Director at Crinetics Pharmaceuticals, Inc. since 2022, and Secretary & Director at Pan Massachusetts Challenge, Inc. Former roles include Director at Can Do Multiple Sclerosis, Independent Director at Neurosense Therapeutics Ltd. from 2021 to 2024, Chief Commercial & Strategy Officer at Editas Medicine, Inc. from 2023 to 2025, Chief Commercial Officer at Magenta Therapeutics, Inc. from 2021 to 2023, Chief Commercial Officer at Ohana Biosciences, Inc. from 2019 to 2021, and VP-Product Development & Commercialization at Biogen, Inc. from 2017 to 2019.
Education includes undergraduate studies at Tufts University and an MBA from F.W.
Olin Graduate School of Business.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 08.07.2026 | 16’300 ( 0.02% ) | 609 946 $ | 30.06.2026 |
Aktive Positionen von Caren Deardorf
| Unternehmen | Position | Beginn |
|---|---|---|
| CRINETICS PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 11.03.2022 |
Pan Mass Challenge
 Pan Mass Challenge Miscellaneous Commercial ServicesCommercial Services Provides fund raises money for life-saving cancer research and treatment | Direktor/Vorstandsmitglied | - |
Pan Massachusetts Challenge, Inc.
 Pan Massachusetts Challenge, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in raising funds for cancer research and treatment | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Caren Deardorf
| Unternehmen | Position | Ende |
|---|---|---|
| EDITAS MEDICINE, INC. | Corporate Officer/Principal | 01.04.2025 |
| NEUROSENSE THERAPEUTICS LTD. | Direktor/Vorstandsmitglied | 27.06.2024 |
| MAGENTA THERAPEUTICS | Corporate Officer/Principal | 07.02.2023 |
Ohana Biosciences, Inc.
 Ohana Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Operates early stage biotechnology company | Corporate Officer/Principal | 01.05.2021 |
| BIOGEN INC. | Corporate Officer/Principal | 01.01.2019 |
Ausbildung von Caren Deardorf
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
75
Beziehungen ersten Grades
11
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 11 |
|---|---|
Biogen, Inc.
 Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Tufts University
 Tufts University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Can Do Multiple Sclerosis
 Can Do Multiple Sclerosis Miscellaneous Commercial ServicesCommercial Services Provides lifestyle empowerment programs | Commercial Services |
Pan Mass Challenge
Pan Mass Challenge Miscellaneous Commercial ServicesCommercial Services Provides fund raises money for life-saving cancer research and treatment | Commercial Services |
Editas Medicine, Inc.
 Editas Medicine, Inc. BiotechnologyHealth Technology Manufactures gene editing medicines | Health Technology |
F.W. Olin Graduate School of Business
 F.W. Olin Graduate School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Crinetics Pharmaceuticals, Inc.
 Crinetics Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets therapeutics for endocrine-related diseases | Health Technology |
Magenta Therapeutics, Inc.
 Magenta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures novel medicines | Health Technology |
Ohana Biosciences, Inc.
Ohana Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Operates early stage biotechnology company | Commercial Services |
Neurosense Therapeutics Ltd.
 Neurosense Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage drug development company | Health Technology |
Pan Massachusetts Challenge, Inc.
Pan Massachusetts Challenge, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in raising funds for cancer research and treatment | Commercial Services |
